Dupixent® Dupilumab 200 mg / 1.14 mL Injection 1.14 mL 2 Syringes

Name: Atopic Dermatitis Treatment
Brand: Dupixent®

DUPIXENT, PFS 200MG/1.14ML 2ML(2/CT)

McKesson #

1149345

Manufacturer #

00024591801

Brand

Dupixent®

Manufacturer

Genzyme

Country of Origin

Unknown

Alternate Manufacturer Number

3954203

Application

Atopic Dermatitis Treatment

Buy American Act (BAA) Compliant

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

45522

Generic Drug Name

Dupilumab

NDC Number

00024591801

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

2 Syringes

Storage Requirements

Requires Refrigeration

Strength

200 mg / 1.14 mL

Trade Agreement Act (TAA) Compliant

Type

Subcutaneous

UNSPSC Code

51202400

Volume

1.14 mL

DUPIXENT is indicated for the treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
DUPIXENT can be used with or without topical corticosteroids
DUPIXENT is indicated as an add-on maintenance treatment in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid dependent asthma
DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP)
Preservative-Free